Promoter analysis and chromosomal mapping of human EBAG9 gene

Citation
K. Ikeda et al., Promoter analysis and chromosomal mapping of human EBAG9 gene, BIOC BIOP R, 273(2), 2000, pp. 654-660
Citations number
24
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ISSN journal
0006291X → ACNP
Volume
273
Issue
2
Year of publication
2000
Pages
654 - 660
Database
ISI
SICI code
0006-291X(20000705)273:2<654:PAACMO>2.0.ZU;2-#
Abstract
The human EBAG9 was previously identified as an estrogen responsive gene us ing CpG-genomic binding site cloning (Watanate et al, (1998) Mel. Cell. Bio l. 18: 442-449). Recently it was revealed that the EBAG9 is identical with RCAS1 which is a cancer cell. surface antigen implicated in immune escape. Here, we isolated and analyzed the 5'-flanking region of human EBAG9 gene. We determined transcription initiation site, which has a homology with an i nitiator element YYCAYYYY, and found that TATA motif was absent. Deletion a nalysis of the 5'-flanking region using MCF-7 breast cancer cells indicated that the sequences -86 to -36 containing the ERE had the basal level of pr omoter activity and the upstream CC-rich region positively regulated the ac tivity. EBAG9 pro meter luciferase reporters containing the ERE could respo nd to estrogen, and electrophoretic mobility shift assay showed that ER alp ha bound to the ERE. Moreover, fluorescent in situ hybridization analysis h as shown that the human EBAG9 gene is located at chromosome 8q23 which is f requently amplified in tumors. These findings suggest that the human EBAG9 might be involved in carcinogenesis as an estrogen responsive gene, (C) 200 0 Academic Press.